Instant Digital Pathology Market Report 2026

Instant Digital Pathology Market Report 2026 Market Overview

• Instant Digital Pathology Market Report 2026 market size has reached to $1.22 billion in 2025 • Expected to grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 18.6% • Growth Driver: Increasing Adoption Of Digital Pathology In Clinical Diagnostics Fueling The Growth Of The Market Due To Rising Demand For Faster, AI-Assisted Diagnostic Workflows • Market Trend: High-Throughput Whole-Slide Scanners Transforming The Market Through Faster Slide Digitization • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Instant Digital Pathology Market?

Instant digital pathology refers to automated, ultra-high-speed slide scanning systems and digital microscopy platforms that convert tissue specimens into high-resolution virtual slides for immediate on-screen analysis and remote consultation. Integrated with cloud networks and AI, these systems allow pathologists to evaluate biopsies instantly, bypassing physical slide transport and accelerating critical cancer diagnostics. The main products of instant digital pathology include hardware, software, and storage systems. Hardware refers to digital pathology equipment such as whole slide scanners and imaging devices that capture, digitize, and process pathology specimens for rapid diagnostic evaluation. These solutions support workflows including scanning, image management, image analysis, and case sharing and reporting. The key applications of disease diagnosis, drug discovery, academic research, and telepathology, while the end-users hospitals, diagnostic laboratories, research institutes, and pharmaceutical and biotechnology companies.

What Is The Instant Digital Pathology Market Growth Forecast?

The instant digital pathology market size is expected to see rapid growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, growing demand for decentralized pathology services, rising need for enhanced diagnostic accuracy, increasing healthcare investment in advanced laboratory solutions, expanding use of virtual pathology consultation models. Major trends in the forecast period include increasing adoption of ultra-fast whole slide imaging systems for real-time pathology assessment, growing integration of remote pathology platforms for instant expert consultation and diagnosis, rising demand for automated tissue analysis workflows to reduce diagnostic turnaround time, increasing deployment of high-resolution digital microscopy solutions in pathology laboratories, growing preference for seamless interoperability between digital pathology systems and laboratory information systems.

What Is The Driver Of The Instant Digital Pathology Market?

The increasing adoption of digital pathology in clinical diagnostics is expected to propel the growth of the instant digital pathology market going forward. Digital pathology refers to the process of converting traditional glass microscope slides into high-resolution digital images using a whole-slide scanner. Adoption of digital pathology in clinical diagnostics is on the rise due to the growing demand for faster, more accurate, and AI-assisted diagnostic workflows that improve laboratory efficiency and reduce turnaround times. Instant digital pathology helps by enabling rapid slide digitization, real-time image sharing, AI-assisted analysis, and faster clinical decision-making while eliminating delays associated with conventional pathology workflows. For instance, in January 2025, according to Labcorp, a US-based clinical laboratory and diagnostics company, approximately one-third (33%) of clinical laboratories had implemented whole-slide imaging, reflecting the continued adoption of digital pathology despite cost-related challenges. Therefore, the increasing adoption of digital pathology in clinical diagnostics is driving the growth of the instant digital pathology industry.

Key Players In The Global Instant Digital Pathology Market

Major companies operating in the instant digital pathology market report are F. Hoffmann-La Roche Ltd., Leica Biosystems, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Sectra AB, Epredia, Proscia Inc., Indica Labs Inc., Paige AI Inc., OptraSCAN Inc., Motic Digital Pathology, Ibex Medical Analytics Ltd., 3DHISTECH Ltd., Huron Digital Pathology Inc., Aiforia Technologies Plc, Lunit Inc., Inspirata Inc., Grundium Oy, PathPresenter Inc., Corista LLC, Morphle Labs Inc.

Global Instant Digital Pathology Market Trends and Insights

Major companies operating in the instant digital pathology market are focusing on developing high-throughput whole-slide scanners and advanced digital pathology platforms, to enable rapid, high resolution digitization of pathology slides. High-throughput whole-slide scanners rapidly convert pathology slides into high-resolution digital images, enabling faster diagnosis and AI-assisted workflows. For instance, in January 2025, Roche Diagnostics, a Switzerland-based diagnostics division of Roche Holding AG, received the U.S. FDA 510(k) clearance for its VENTANA DP 600 high-volume slide scanner as part of the Roche Digital Pathology Dx system. The scanner enables instant high-resolution slide digitization, rapid whole-slide image acquisition, and accelerated digital pathology workflows, allowing pathologists to perform faster primary diagnoses and clinical decision-making. It is designed for high throughput pathology laboratories, supporting continuous slide scanning with consistent image quality across large sample volumes. It integrates seamlessly with Roche's digital pathology software ecosystem, enabling efficient image management, case review, and collaboration among pathologists. By reducing manual slide handling and supporting AI enabled image analysis applications, the system helps improve laboratory productivity, diagnostic accuracy, and turnaround times.

What Are Latest Mergers And Acquisitions In The Instant Digital Pathology Market?

In August 2025, Tempus AI, a US-based precision medicine and artificial intelligence company, acquired Paige for $81.25 million. Through this acquisition, Tempus AI aims to strengthen its digital pathology and AI capabilities by expanding its repository of clinically annotated pathology data, accelerating the development of AI-powered diagnostic tools, and enhancing precision oncology solutions for improved clinical decision-making. Paige is a US-based company specializing in AI-powered digital pathology solutions that support cancer diagnosis, biomarker discovery, and pathology workflow optimization.

What Defines the Instant Digital Pathology Market?

The instant digital pathology market consists of revenues earned by entities by providing services such as digital slide scanning, image analysis, pathology workflow management, remote pathology consultation, artificial intelligence-assisted diagnostic support, cloud-based image storage, and system integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The instant digital pathology market also includes sales of dual wide-coverage computed tomography scanners, detector arrays, X-ray tubes, gantry systems, patient tables, high-voltage generators, collimators, slip ring assemblies, cooling systems and operator consoles designed for high-resolution volumetric diagnostic imaging. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Instant Digital Pathology Market Report 2026?

The instant digital pathology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the instant digital pathology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.